BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$80.91 USD
-1.26 (-1.53%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $80.92 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/29/2024
Time: -- |
6/2024 | $0.61 | -6.01% |
Earnings Summary
For their last quarter, BioMarin Pharmaceutical (BMRN) reported earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.60 per share. This reflects a positive earnings surprise of 18.33%. Look out for BMRN's next earnings release expected on July 29, 2024. For the next earning release, we expect the company to report earnings of $0.61 per share, reflecting a year-over-year increase of 12.96%.
Earnings History
Price & Consensus
Zacks News for BMRN
BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
BMRN: What are Zacks experts saying now?
Zacks Private Portfolio Services